Literature DB >> 32140883

Gold nanoparticles enhance immune responses in mice against recombinant classical swine fever virus E2 protein.

Yafei Li1,2, Qianyue Jin1,3, Peiyang Ding4, Wen Zhou1,2, Yongxiao Chai1,2, Xufeng Li1,5, Yao Wang1,5, Gaiping Zhang6,7,8,9,10.   

Abstract

OBJECTIVE: To create a novel subunit vaccine that used AuNPs as carriers to enhance immune responses in mice against recombinant classical swine fever virus E2 protein (CSFV E2).
RESULTS: Gold nanoparticles (AuNPs) were successfully coupled to the E2 protein and formed stable particle complexes called E2 conjugated AuNPs (E2-AuNPs). In vitro studies have shown that the E2-AuNPs complex has the same immunogenicity as the E2 protein, and AuNPs can promote the phagocytosis of the E2 protein by antigen-presenting cells (APCs). In vivo results of BALB/c mice showed that the antibody levels, lymphocyte proliferation index, IFN-γ and IL-10 cytokines induced by E2-AuNPs were relatively higher than those of E2 or AuNPs group.
CONCLUSIONS: This finding demonstrated the potential of using AuNPs as a carrier to enhance the body's immune response for developing CSFV subunit vaccines. This model also contributes to the development of other flavivirus subunit vaccines, such as hepatitis C virus (HCV) and bovine viral diarrhea virus (BVDV).

Entities:  

Keywords:  Carrier; Classical swine fever virus; E2 protein; Gold nanoparticles; Subunit vaccine

Mesh:

Substances:

Year:  2020        PMID: 32140883     DOI: 10.1007/s10529-020-02853-w

Source DB:  PubMed          Journal:  Biotechnol Lett        ISSN: 0141-5492            Impact factor:   2.461


  8 in total

Review 1.  Efficacy and Immune Response Elicited by Gold Nanoparticle- Based Nanovaccines against Infectious Diseases.

Authors:  Anirban Sengupta; Mohammad Azharuddin; Noha Al-Otaibi; Jorma Hinkula
Journal:  Vaccines (Basel)       Date:  2022-03-24

Review 2.  Nanotechnology against the novel coronavirus (severe acute respiratory syndrome coronavirus 2): diagnosis, treatment, therapy and future perspectives.

Authors:  Hamid Rashidzadeh; Hossein Danafar; Hossein Rahimi; Faezeh Mozafari; Marziyeh Salehiabar; Mohammad Amin Rahmati; Samaneh Rahamooz-Haghighi; Navid Mousazadeh; Ali Mohammadi; Yavuz Nuri Ertas; Ali Ramazani; Irada Huseynova; Rovshan Khalilov; Soodabeh Davaran; Thomas J Webster; Taras Kavetskyy; Aziz Eftekhari; Hamed Nosrati; Mehdi Mirsaeidi
Journal:  Nanomedicine (Lond)       Date:  2021-03-08       Impact factor: 5.307

Review 3.  Research Progress and Challenges in Vaccine Development against Classical Swine Fever Virus.

Authors:  Qiang Wei; Yunchao Liu; Gaiping Zhang
Journal:  Viruses       Date:  2021-03-10       Impact factor: 5.048

4.  A Self-Assembling Ferritin Nanoplatform for Designing Classical Swine Fever Vaccine: Elicitation of Potent Neutralizing Antibody.

Authors:  Zekai Zhao; Xinghua Chen; Yibao Chen; Hui Li; Kui Fang; Huanchun Chen; Xiangmin Li; Ping Qian
Journal:  Vaccines (Basel)       Date:  2021-01-13

Review 5.  Immunotherapeutic nanoparticles: From autoimmune disease control to the development of vaccines.

Authors:  Romina Mitarotonda; Exequiel Giorgi; Tatiane Eufrasio-da-Silva; Alireza Dolatshahi-Pirouz; Yogendra Kumar Mishra; Ali Khademhosseini; Martin F Desimone; Mauricio De Marzi; Gorka Orive
Journal:  Biomater Adv       Date:  2022-04-22

Review 6.  The Development of Classical Swine Fever Marker Vaccines in Recent Years.

Authors:  Fangfang Li; Bingke Li; Xinni Niu; Wenxian Chen; Yuwan Li; Keke Wu; Xiaowen Li; Hongxing Ding; Mingqiu Zhao; Jinding Chen; Lin Yi
Journal:  Vaccines (Basel)       Date:  2022-04-13

Review 7.  Metal-Based Compounds in Antiviral Therapy.

Authors:  Chiara Abate; Federica Carnamucio; Ottavia Giuffrè; Claudia Foti
Journal:  Biomolecules       Date:  2022-07-03

Review 8.  Gold nanoparticles for preparation of antibodies and vaccines against infectious diseases.

Authors:  Lev A Dykman
Journal:  Expert Rev Vaccines       Date:  2020-04-28       Impact factor: 5.217

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.